Popular diabetes and weight loss drug doubles risk of eye disease that causes blindness, study warns
Monday, 28 July 2025 ()
(NaturalNews) Popular diabetes and weight-loss drug tirzepatide (Mounjaro/Zepbound) more than doubles the risk of severe eye disease, with 1.1% of users develop...
|
||||
You Might Like |
||||
